$SNDL: A MASSIVE 1600% OPPORTUNITY FOR THIS CANNIBIS MICROCAP!NASDAQ:SNDL A MASSIVE 1600% OPPORTUNITY FOR THIS CANNIBIS MICROCAP STOCK! 🌿🤯
Are cannabis stocks back?!
3 Reasons Why in this Video: 📹
1⃣ My "High Five Trade Setup" strategy
2⃣ Catalyst: Decriminalization of MJ in Germany back in April and acquisition of NOVA.
3⃣ Symmetrical Triangle Breakout
Video analysis 2/5 dropping today. Stay tuned!🔔
Like ♥️ Follow 🤳 Share 🔂
Are cannabis stocks back?! Let me know in the comments below.
Not financial advice.
OTC:CRLBF OTC:TCNNF NASDAQ:TLRY TSX:ACB OTC:CURLF OTC:GTBIF AMEX:IWM NASDAQ:QQQ #TradingSignals #TradingTips #options #optiontrading #StockMarket #stocks #CannabisLegalisierung
Cannabisstockstobuy
Tilray Brands Unveils Exciting 420 Product Lineup: Stock up 18%As the cannabis industry continues to evolve, Tilray Brands, Inc. ( NASDAQ:TLRY ) emerges as a frontrunner in the global cannabis lifestyle and consumer packaged goods market. In a recent announcement, Tilray ( NASDAQ:TLRY ) unveiled its latest product lineup and 420 celebratory activations across Canada, offering consumers an array of diverse cannabis products from its leading brands.
Tilray Brands ( NASDAQ:TLRY ), known for its commitment to quality and innovation, showcases an impressive selection of flower, beverages, pre-rolls, and vapes, catering to both seasoned cannabis enthusiasts and curious newcomers alike.
Flower Selection:
Redecan Space Age Cake, Good Supply Melon Dream, and Broken Coast EmergenZ and Cherry Cheesecake are among the standout strains offered, each boasting unique aromas and taste profiles that promise to elevate the cannabis experience.
Beverage Innovation:
XMG+ Non-Carbonated Banana Brain-Freeze and Berry Rocket, Solei Cold Brews in Peach Cranberry and Wildberry Hibiscus, and Mollo Seltzers in Lemon, Mango, and Pineapple showcase Tilray's commitment to providing consumers with innovative and refreshing beverage options infused with THC and other cannabinoids.
Pre-Rolls for Convenience:
Good Supply's 'Cherry on Top' Blunts, Redecan Hemp'd Khalifuel Redees, and Canaca Darts in Berries & Cream and Twisted Citrus offer convenient and pre-rolled options for consumers seeking quality and consistency.
Vape Excellence:
Good Supply Gooey Gold and Cherry Loops vapes deliver high potency and rich flavors, enhancing the vaping experience with every inhale.
In celebration of 420, Tilray Brands invites consumers to explore these exciting new products through a series of educational budtender events hosted in partnership with over 1000 Canadian cannabis retailers nationwide. These events offer a unique opportunity for consumers to learn about Tilray Brands' products and the ever-changing landscape of cannabis innovation and culture.
With a commitment to quality, diversity, and consumer satisfaction, Tilray Brands ( NASDAQ:TLRY ) continues to push the boundaries of cannabis innovation, setting the standard for excellence in the industry. Whether it's the creamy vanilla notes of Redecan Space Age Cake or the tropical sweetness of XMG+ Non-Carbonated Banana Brain-Freeze, Tilray Brands offers something for every cannabis enthusiast to enjoy.
Technical Outlook
Tilray Brands Inc. ( NASDAQ:TLRY ) stock is up by 18.26% prior to new product lineup news. In our recent technical Outlook on Tilray Brands ( NASDAQ:TLRY ) stock, we predicted the stock to spark a bullish breakout after forming a symmetrical triangle pattern. which did fill the order.
Wednesday, 4th April 2024. NASDAQ:TLRY is trading above the 200-day Moving Averages (MA) with a bullish Relative Strength Index (RSI) of 77.82 indicating an overbought position or continuation of the current trend.
Jazz Pharmaceuticals: High Life 🍁It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the corrective low, it can turn back up and start a sturdy upwards trend.
CNBX leader in cancer related cannabinoid-based medicineCNBX Cannabics Pharmaceuticals has an agreement with Purisys, a leading Active Pharmaceutical Iingredient manufacturer, to use its API in Phase I/II (a) clinical studies that it is planning to launch in 2022.
So this year will be quite bullish for CNBX
Cannabics Pharmaceuticals is a U.S. public company and a global leader in the development of cancer related cannabinoid-based medicine. It engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer.
52 Week Range 0.08 - 0.60
Market Cap 15.163M
Short term upside: $0.20
After they begin the Phase I/II (a) clinical studies, the stock can reach once again its 52 week highs.
SNDL projected $540 million in sales in 2022Wall Street has Sundial pegged to bring in almost $540 million in sales in 2022, up from an estimated $50.5 million this year.
They are also buying Alcanna in a stock deal.
The board of directors of Alcanna unanimously recommends Alcanna Shareholders vote “FOR” the Arrangement Resolution.
The Special Meeting of Alcanna Shareholders is postponed to January 7, 2022
1.2usd is my minimum price target.
Long Term Buy on HITIAs many of you already know, I've been bullish on HITI for quite some time, waiting for the right entry. This is one of my favorite cannabis stocks, and I'm bullish the cannabis sector overall. This may not be a quick play; I'm expecting to hold my cannabis stocks for quite some time.
On the daily chart, HITI made some lower lows, while the RSI made higher highs. This divergence is nice, but not enough for me to enter.
On the hourly chart, we saw the asset hold this support line after an upward move on November 8th. In addition, price was above the 50SMA on the daily chart. I entered at end of day on November 8th.
By the end of the week, HITI was up testing the 200 period SMA. If we break north of this line, I will continue adding to my position to build it.
CHRONOS ON A KEY LEVELWith international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™.
Bullish divergence on the weekly coinciding with a market level where statistically over time this asset has always reacted. Interesting scenario and adequate space for different investment strategies. Medium / long term target price $ 9.60 - $ 13.
WeedMD: We are not seeing Ghosts! 👻👻Yes, WeedMD has been relatively weak over the last months, but we are within that yellow target box and, accordingly, are waiting for the breakout on the long side. The price needs to reach regions around C$0.59 in the first place, before moving on to a corrective movement. After that, we are set to push for massive increases.
Stay trading!
How clever are Clever Leaves investors?Nice gap up candlestick and rising volume... is this an initiation gap up or a short term short squeeze/ bear rally? Awaiting to see how it behaves in the next sessions around the gap, in case it half closes it and then moves upwards i am going to start my initial position and build gradually from there.
Aphria Inc: Green Light For Green Life! 🌿🌿🌿Recently, Aphria went all the way through our blue trading zone and we believe that the bearish movement should be over now. From here, we expect the stock’s price to increase again and crush through the mark at CAD28.78. All in all, we expect prices of above CAD37 to become reality in the near future. With a probability of only 30%, there is a chance that the price drops below CAD17.51, but this gives us only more profitable entry points.
Don’t miss this chance!
MJ Analytics generates six figure sales increaseMJ Analytics, an Akerna product built on Domo's modern BI platform, generates six figure sales increase
Within less than 90 days of launching MJ Analytics, the platform has generated a six figure increase in sales and helped clients reduce manual reporting workflows by 90% through the use of scheduled reports. With a 95% positive product feedback based on recent surveys, MJ Analytics is proving its value as a first-of-its-kind actionable insights product.
Since launch, MJ Analytics has:
Processed a total of 5.1 million queries
Averaged 3.6k queries a day with peaks of 20k queries during month ends
Signed up 40 clients for Premium Analytics, through either a trial or paid subscription
finance.yahoo.com
New Year's Eve Marks Biggest Cannabis Sales Day of 2020
The Christmas holiday period (12/18-12/24) generated $427 million . Traditionally, the Friday preceding Christmas is the biggest sales day of the period. However, this year the Wednesday before Christmas (12/23) saw the most significant bump in sales with a 76% increase in daily sales. Totaling $87.3 million, the Wednesday before Christmas was the third-largest sales day of the year, only slightly behind Green Wednesday with $87.4 million.
Previously projected to see depressed sales due to an anticipated decrease in group gatherings and parties as the result of COVID-19 restrictions, New Year's Eve exceeded all expectations. The year-end holiday saw approximately $89.4 million in sales, easily surpassing Green Wednesday and becoming the biggest cannabis sales day of the year.
finance.yahoo.com